TW201932592A - An Taiwanofungus camphoratus culture medium for increasing the fruiting bodies and triterpenoids - Google Patents
An Taiwanofungus camphoratus culture medium for increasing the fruiting bodies and triterpenoids Download PDFInfo
- Publication number
- TW201932592A TW201932592A TW107102714A TW107102714A TW201932592A TW 201932592 A TW201932592 A TW 201932592A TW 107102714 A TW107102714 A TW 107102714A TW 107102714 A TW107102714 A TW 107102714A TW 201932592 A TW201932592 A TW 201932592A
- Authority
- TW
- Taiwan
- Prior art keywords
- antrodia
- antrodia camphorata
- culture medium
- triterpenes
- fruit body
- Prior art date
Links
- 241001486992 Taiwanofungus camphoratus Species 0.000 title claims abstract description 60
- 239000001963 growth medium Substances 0.000 title claims abstract description 16
- 150000003648 triterpenes Chemical class 0.000 title claims abstract description 14
- 230000001965 increasing effect Effects 0.000 title claims abstract description 8
- 229920001817 Agar Polymers 0.000 claims abstract description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 7
- 239000008272 agar Substances 0.000 claims abstract description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 12
- 239000002609 medium Substances 0.000 claims description 12
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 4
- 235000013339 cereals Nutrition 0.000 claims description 4
- 150000007857 hydrazones Chemical class 0.000 claims description 4
- 235000018102 proteins Nutrition 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims 3
- 241000736199 Paeonia Species 0.000 claims 2
- 108010073771 Soybean Proteins Proteins 0.000 claims 1
- 235000019710 soybean protein Nutrition 0.000 claims 1
- 108010080698 Peptones Proteins 0.000 abstract description 4
- 239000001888 Peptone Substances 0.000 abstract description 2
- 235000019319 peptone Nutrition 0.000 abstract description 2
- 206010067125 Liver injury Diseases 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 231100000753 hepatic injury Toxicity 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 230000001154 acute effect Effects 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 9
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 6
- 108010082126 Alanine transaminase Proteins 0.000 description 6
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 6
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 6
- 239000000306 component Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000012364 cultivation method Methods 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 241000123370 Antrodia Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 101000878457 Macrocallista nimbosa FMRFamide Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本發明係與藥用真菌的培養有關;特別是指一種適用於可增加牛樟芝子實體及提升三萜類之牛樟芝培養基成分。The present invention relates to the cultivation of medicinal fungi; in particular, it refers to an Antrodia cinnamomeus medium component that can increase the fruit body of Antrodia camphorata and enhance triterpenes.
牛樟芝又名牛樟菇,是台灣特有的世界六大藥用真菌,只生長在台灣特有百年以上的牛樟樹樹幹腐朽的內壁,或枯死倒伏的牛樟樹木材潮濕表面,因其採集不易,加上野生牛樟木近年已被台灣政府列為保育類生物之一,不允許出口。目前只有台灣有,因此異常珍貴,被作為台灣至寶,森林中的紅寶石,靈芝之王。Antrodia cinnamomea, also known as Antrodia camphorata, is Taiwan’s six largest medicinal fungi in the world. It grows only on the decayed inner wall of the trunk of Antrodia camphorata, which is endemic to Taiwan for more than 100 years, or on the moist surface of dead and fallen Antrodia camphora wood. The wild Antrodia camphorata has been listed as one of the conservation creatures by the Taiwan government in recent years and is not allowed to be exported. Currently only in Taiwan, it is extremely precious and is regarded as the treasure of Taiwan, the ruby in the forest, and the king of Ganoderma.
牛樟芝的藥用功效包含:The medicinal properties of Antrodia camphorata include:
一、解毒、排毒;1. Detoxification and detoxification;
二、抵抗病毒侵害、預防流行性感冒、提高免疫力,因牛樟芝成份中含有的多醣,可增進人體內的免疫調節。2. Resist virus infestation, prevent influenza, and improve immunity. The polysaccharides contained in Antrodia camphorata can improve immune regulation in the human body.
三、防癌、抑制癌細胞的生長;3. Prevent cancer and inhibit the growth of cancer cells;
四、治療肝炎、肝硬化、肝癌,因牛樟芝含有豐富的三萜類及多醣,具有保護肝臟、促進肝細胞再生、對抗肝癌的療效。Fourth, the treatment of hepatitis, cirrhosis, liver cancer, because Antrodia camphorata is rich in triterpenes and polysaccharides, has the effect of protecting the liver, promoting liver cell regeneration, and fighting liver cancer.
五、治療各種心腦血管疾病,其中,牛樟芝除了能降低血液中的膽固醇和脂肪含量外,其腺苷能降低血小板的凝結功能,因此能治療各種心腦血管疾病,如高血壓、低血壓、動脈硬化等等。5. Treatment of various cardiovascular and cerebrovascular diseases. Among them, Antrodia cinnamomea can reduce the cholesterol and fat content in the blood, and its adenosine can reduce the clotting function of platelets, so it can treat various cardiovascular and cerebrovascular diseases, such as hypertension, hypotension, Arteriosclerosis and so on.
隨著人們對於牛樟芝及其藥效認知度的提高,其保健需求日益增長,然而,目前存在的培養法:段木栽培法、個體培養法及液體發酵法皆無法產出高質、量產且短週期的牛樟芝。亦即,目前仍缺乏能培養出高質量且短週期之牛樟芝的培育方式。As people's awareness of Antrodia camphorata and its medicinal effects improves, its health care needs are increasing. However, the current cultivation methods: segment wood cultivation method, individual cultivation method and liquid fermentation method can not produce high quality, mass production and Antrodia cinnamomea with short cycle. That is, there is still a lack of cultivation methods that can produce high quality and short cycle Antrodia camphorata.
有鑑於此,本發明之目的在於提供一種可增加牛樟芝子實體及提升三萜類之牛樟芝培養基,建立牛樟芝最適培養基及各成分指標。In view of this, the purpose of the present invention is to provide an Antrodia cinnamomea medium that can increase Antrodia cinnamomea fruit bodies and enhance triterpenes, and establish an optimal medium for Antrodia cinnamomea and various component indexes.
緣以達成上述目的,本發明提供的一種可增加牛樟芝子實體及提升三萜類之牛樟芝培養基包含有瓊脂、D-葡萄糖、麥芽浸膏及0.5至1%之蛋白腖。In order to achieve the above object, the present invention provides an Antrodia cinnamomea media that can increase the fruit body of Antrodia camphorata and enhance triterpenes, including agar, D-glucose, malt extract, and 0.5 to 1% protein hydrazone.
本發明之效果在於添加植物性蛋白腖於牛樟芝培養基中,有效提高牛樟芝的質量。The effect of the present invention is to add plant protein pouches to Antrodia camphorata culture medium, and effectively improve the quality of Antrodia camphorata.
為能更清楚地說明本發明,茲舉下列較佳實施例詳細說明如後。In order to explain the invention more clearly, the following preferred embodiments are described in detail as follows.
實施例一 牛樟芝最佳培養條件探索及其成分分析Example 1 Exploration of the best cultivation conditions of Antrodia camphorata and its component analysis
菌種來源Source of strain
中華科技大學真菌與植物生技團隊山上採集新鮮牛樟菇後分離而得。The fungus and plant biotechnology team from the University of Science and Technology of China collected the fresh Antrodia camphorata on the mountain and separated them.
最佳培養條件探索Explore the best cultivation conditions
MEA培養基主要是用來進行真菌(黴菌、酵母菌等)的分離、計數和培養,而本發明培養基包含基本成分:五穀雜糧(玉米、稻米或小麥等),其中包含10-15%的紫米,故色澤偏紅,另外更添加了0.1-1%的蛋白腖,其中,蛋白腖減緩成長速度,故能長出類似子實體結構。The MEA medium is mainly used for the separation, counting and cultivation of fungi (mould, yeast, etc.), and the medium of the present invention contains the basic ingredients: grains (corn, rice or wheat, etc.), which contains 10-15% of purple rice Therefore, the color is reddish, and 0.1-1% protein peptone is added. Among them, the protein peptone slows the growth rate, so it can grow a similar fruiting body structure.
牛樟芝子實體的培養裝置主要包含有:一袋體,由一環壁與一頂壁所構成,使其頂側形成一開口,內部形成一容置空間。前述之培養基容置於該袋體的容置空間中,藉以培養牛樟芝。利用此種培養方式可大幅增加產量與降低成本。The cultivation device of Antrodia cinnamomea fruit body mainly includes: a bag body, which is composed of a ring wall and a top wall, so that an opening is formed on the top side, and an accommodating space is formed inside. The aforementioned culture medium is accommodated in the accommodating space of the bag body to cultivate Antrodia camphorata. Using this cultivation method can greatly increase production and reduce costs.
本發明之實驗以固態培養基為主,並以五種培養基條件進行培養,該五種培養基分別以代號MEA、P0.1、P0.5、A0.1、A0.5表示,其中對照組為MEA培養基,實驗組為加入0.1%及0.5%之動、植物性蛋白腖,如表一所示。 表一、各組培養基之成份
上表之配置方法為:將瓊脂、D-葡萄糖、麥芽浸膏及蛋白腖加入蒸餾水配製成1公升溶液後,於121℃高溫下滅菌15分鐘,再將PH值調至5.6 ± 0.2。其中,瓊脂、D-葡萄糖及麥芽浸膏之較佳重量百分濃度分別為2%、4%及2%。The configuration method in the above table is as follows: agar, D-glucose, malt extract and protein hydrazone are added to distilled water to prepare a 1 liter solution, which is sterilized at 121℃ for 15 minutes, and then the pH value is adjusted to 5.6 ± 0.2. Among them, the preferred weight percent concentrations of agar, D-glucose and malt extract are 2%, 4% and 2%, respectively.
直徑生長與乾重比較Comparison of diameter growth and dry weight
牛樟菌接種時以鑽孔器進行打洞,以控制每次接種的菌種直徑都相同,再以挑菌棒取一塊放入培養基中央,之後放入26℃培養箱進行培養1到2個月,測量並紀錄菌絲生長直徑,之後在烘箱中烘乾46小時,烘乾後用剪刀剪去不含樟芝菌絲的培養基部分,並秤重記錄,結果如下表二。 表二、牛樟菌於五種培養基下之直徑生長與乾重比較
將直徑與乾重增加最顯著之組別P0.5及A0.5(培養2個月後)進行高效液相色譜法(HPLC)分析,結果如第1圖顯示,圖中所標記的A、B峰於P0.5中單獨存在,且C峰較高。是以,確定牛樟芝最適固體培養條件為P0.5組所含之成份。The P0.5 and A0.5 groups with the most significant increase in diameter and dry weight (after 2 months of cultivation) were analyzed by high-performance liquid chromatography (HPLC). The results are shown in Figure 1, where A, Peak B exists alone in P0.5, and peak C is higher. Therefore, determine the best solid culture conditions of Antrodia camphorata as the components contained in P0.5 group.
指標成分分析Index component analysis
本發明培養基(P0.5)之特徵在於添加0.5-1%之植物性蛋白腖,其指標成分含量如下表三。 表三、本發明培養基之指標成分含量
實施例二 牛樟芝對於肝臟損傷之修護Example 2 Antrodia cinnamomea to repair liver damage
乙醇誘導之急性酒精肝損傷小鼠Alcohol-induced acute alcohol liver injury in mice
C57BL/6小鼠經過一周的適應以後,隨機分為三组,每組六隻。分組方式如下表四: 表四、牛樟芝對於肝臟損傷之修護試驗之組別
其中,生理鹽水和牛樟芝菌粉每天上午9點給予,連續灌胃 30 天之後,小鼠禁食6小時,然後灌胃酒精(5.0 g/kg,60%)。 16小時後小鼠處死並取血,其血清用來測定各項生化參數;另取部分小鼠肝臟,加入定量生理鹽水製備成肝組織勻漿液,並評估其肝損傷程度。Among them, physiological saline and Antrodia cinnamomea powder were given every day at 9 am. After continuous oral gavage for 30 days, the mice were fasted for 6 hours and then gavage of alcohol (5.0 g/kg, 60%). After 16 hours, the mice were sacrificed and blood was taken. The serum was used to measure various biochemical parameters. Another part of the liver of the mice was added with quantitative physiological saline to prepare liver tissue homogenate, and the degree of liver injury was evaluated.
牛樟芝對急性酒精肝損傷標誌性酶之活性的影響Effect of Antrodia Cinnamomea on Acute Alcoholic Liver Injury
谷丙轉氨酶(ALT)和穀草轉氨酶(AST)是肝臟內的標誌性酶類,當肝臟損傷後,二者會產生異常升高。該實驗考察牛樟芝菌粉對急性酒精肝損傷小鼠谷丙轉氨酶和穀草轉氨酶含量的影響,結果如第2圖所示。Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are the hallmark enzymes in the liver. When the liver is damaged, both of them will abnormally increase. This experiment investigated the effects of Antrodia camphorata powder on the content of alanine aminotransferase and aspartate aminotransferase in mice with acute alcohol liver injury. The results are shown in Figure 2.
與對照組相比,模型組小鼠的谷丙轉氨酶和穀草轉氨酶含量明顯升高。牛樟芝菌粉能顯著的抑制急性酒精肝損傷小鼠谷丙轉氨酶和穀草轉氨酶含量的升高,其中,與空白組比較,***p < 0.001;與模型組比較,# # #p < 0.001,# #p < 0.01。Compared with the control group, the alanine aminotransferase and aspartate aminotransferase contents of the model group were significantly increased. Antrodia cinnamomea powder can significantly inhibit the increase of alanine aminotransferase and aspartate aminotransferase content in mice with acute alcohol liver injury. Among them, compared with the blank group, ***p <0.001; compared with the model group, # # #p < 0.001, # #p < 0.01.
牛樟芝對急性酒精肝損傷之抗氧化活性的影響Effect of Antrodia camphorata on antioxidant activity of acute alcohol liver injury
MDA為脂質過氧化所產生的二級產物,SOD和GSH-Px是肝臟清除過氧化物,防止氧化性損傷的關鍵酶,肝臟MDA含量以及SOD和GSH-Px酶活性可反應肝臟內脂質過氧化及氧化性損傷的程度。該實驗考察牛樟芝菌粉對急性酒精肝損傷小鼠肝臟MDA含量以及SOD和GSH-Px酶活性的影響,結果如第3圖所示。MDA is a secondary product produced by lipid peroxidation. SOD and GSH-Px are the key enzymes for the liver to eliminate peroxides and prevent oxidative damage. The liver MDA content and the activities of SOD and GSH-Px enzymes can reflect lipid peroxidation in the liver And the degree of oxidative damage. This experiment investigated the effects of Antrodia cinnamomea powder on the liver MDA content and SOD and GSH-Px enzyme activities in mice with acute alcohol liver injury. The results are shown in Figure 3.
與對照組相比,模型組小鼠的MDA含量明顯升高,而SOD和GSH-Px活性顯著降低。牛樟芝菌粉能顯著的抑制急性酒精肝損傷小鼠MDA含量的升高,以及SOD和GSH-Px活性的降低,其中,與空白組比較,***p < 0.001; 與模型組比較,# #p < 0.01。Compared with the control group, the MDA content of the model group was significantly increased, while the activities of SOD and GSH-Px were significantly reduced. Antrodia camphorata powder can significantly inhibit the increase of MDA content and the decrease of SOD and GSH-Px activity in mice with acute alcohol liver injury. Among them, compared with the blank group, ***p <0.001; compared with the model group, # # p <0.01.
以上實驗顯示,牛樟芝菌粉對小鼠急性酒精肝具有一定的保護作用。The above experiments show that Antrodia camphorata powder has a certain protective effect on acute alcoholic liver in mice.
綜上所述,利用本發明牛樟芝培養基之成分確實能夠產出高質量且短週期之牛樟芝。In summary, the composition of the Antrodia camphorata culture medium of the present invention can indeed produce high-quality and short-cycle Antrodia camphorata.
以上所述僅為本發明較佳可行實施例而已,舉凡應用本發明說明書及申請專利範圍所為之等效變化,理應包含在本發明之專利範圍內。The above is only the preferred and feasible embodiments of the present invention, and any equivalent changes in applying the description of the present invention and the scope of patent application should be included in the patent scope of the present invention.
第1圖為培養基A0.5及培養基P0.5之高效液相色譜法(HPLC)分析。 第2圖為本發明牛樟芝對急性酒精肝損傷小鼠之ALT和AST的影響。 第3圖為本發明牛樟芝對急性酒精肝損傷小鼠MDA、GSH-Px和SOD水平的影響。Figure 1 shows high-performance liquid chromatography (HPLC) analysis of medium A0.5 and medium P0.5. Figure 2 shows the effect of Antrodia camphorata on ALT and AST in mice with acute alcohol liver injury. Figure 3 shows the effect of Antrodia camphorata on MDA, GSH-Px and SOD levels in mice with acute alcohol liver injury.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW107102714A TWI666315B (en) | 2018-01-25 | 2018-01-25 | An Taiwanofungus camphoratus culture medium for increasing the fruiting bodies and triterpenoids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW107102714A TWI666315B (en) | 2018-01-25 | 2018-01-25 | An Taiwanofungus camphoratus culture medium for increasing the fruiting bodies and triterpenoids |
Publications (2)
Publication Number | Publication Date |
---|---|
TWI666315B TWI666315B (en) | 2019-07-21 |
TW201932592A true TW201932592A (en) | 2019-08-16 |
Family
ID=68049687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW107102714A TWI666315B (en) | 2018-01-25 | 2018-01-25 | An Taiwanofungus camphoratus culture medium for increasing the fruiting bodies and triterpenoids |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI666315B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102283019B (en) * | 2011-07-06 | 2016-08-03 | 佛山市顺德区今日景艺生物科技有限公司 | The method of artificial rapid Antrodia camphorata breeding |
CN102356728B (en) * | 2011-08-15 | 2013-06-26 | 江南大学 | Solid culturing method for increasing active product yield of antrodia camphorata |
CN103444430B (en) * | 2012-06-04 | 2015-07-22 | 慧普生技股份有限公司 | Culture method for Antrodia |
TWI543706B (en) * | 2013-08-19 | 2016-08-01 | 東海大學 | The method for culturing antrodia cinnamomea |
-
2018
- 2018-01-25 TW TW107102714A patent/TWI666315B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TWI666315B (en) | 2019-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10356988B2 (en) | Method for culturing Ophiocordyceps sinensis | |
KR100199920B1 (en) | The method of culturing cordyceps | |
KR102195870B1 (en) | Chaga fungus and its application | |
CN105861321A (en) | Ganoderma leucocontextum new strain and cultivation method and application thereof | |
CN109337895A (en) | A kind of production method of good quality and high output selenium-enriched hericium erinaceus strain | |
CN107629965A (en) | A kind of preparation method of dendrobium candidum fungi fermentation product and its fermented product and application | |
TW201200143A (en) | A method to improve cordycepin of Solid-state cultivation | |
WO2022100568A1 (en) | Tricholoma matsutake and method for producing ergothioneine thereby | |
CN103918472B (en) | The cultivation basswood method of Antrodia Camphorata | |
CN104402575A (en) | Antrodia medium formula and antrodia cultivation method | |
CN105779299B (en) | Paecilomyces hepiali strain for producing adenosine and mannitol substances and application thereof | |
CN108901615A (en) | Utilize the method for trollflower pharmacological property culture medium culture cordyceps mycelium | |
CN114592013A (en) | Preparation method and application of cordyceps sobolifera enzyme | |
Sawant et al. | Effect of fungal infections on nutritional value of papaya fruits | |
TWI422680B (en) | Culture medium for culturing fruiting bodies of antrodia cinnamomea and method for culturing the same | |
CN1456661A (en) | Large scale zhangzhi fungus deep fermenting process | |
Li et al. | Fusarium solani causing root rot disease on Gastrodia elata in Shaxi, China | |
TWI666315B (en) | An Taiwanofungus camphoratus culture medium for increasing the fruiting bodies and triterpenoids | |
Wang et al. | Enhanced production of mycelial biomass and extracellular polysaccharides in caterpillar-shaped medicinal mushroom Cordyceps sinensis CS001 by the addition of palmitic acid | |
CN110896784A (en) | Substitute cultivation medium, substitute cultivation method and application of inonotus obliquus | |
CN108353728A (en) | A kind of Antrodia camphorata culture medium for increasing Antrodia camphorata fructification and promoting triterpenes | |
TWM559891U (en) | Device for increasing fruiting body of Antrodia camphorate | |
CN114600706A (en) | Artificial culture method of cordyceps militaris | |
CN110656050B (en) | Inonotus obliquus strain obtained through ultraviolet mutagenesis | |
CN109619168B (en) | Application of cinnamon essential oil in bacteriostasis and fresh keeping of blueberries and application method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |